Mikhail Gilyarov

1.3k citations
2 papers · 37 indexed · h-index 2
Topics
Cardiovascular Function and Risk Factors (1 paper)Metabolism, Diabetes, and Cancer (1 paper)COVID-19 Clinical Research Studies (1 paper)
Journals
Inflammation ResearchDiabetes Mellitus
Partner nations
Russia

In The Last Decade

Mikhail Gilyarov

2 papers receiving 31 citations

Peers

Mikhail Gilyarov
Comparison fields: 5 of 28
  • Infectious Diseases 20
  • Neurology 16
  • Immunology 7
  • Molecular Biology 4
  • Radiology, Nuclear Medicine and Imaging 4
Replace Veronica Vassia with:
Veronica Vassia Italy
María Castillo de la Osa Spain
Marco Lanzillotta Italy
Giuseppina Affinito Italy
John Bassett United Kingdom
Dale Chappell United States
Raffaella Landi Italy
Natália S. Brunetti Brazil
Paul Quentric France
Marisa Di Natale Spain
Mikhail Gilyarov relative to Veronica Vassia Italy Veronica Vassia's profile →
Citations per field
00.5×2.6×
Veronica Vassia · 1×
Citations per year

Countries citing papers authored by Mikhail Gilyarov

Since Specialization
Citations

This map shows the geographic impact of Mikhail Gilyarov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikhail Gilyarov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikhail Gilyarov more than expected).

Fields of papers citing papers by Mikhail Gilyarov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikhail Gilyarov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikhail Gilyarov. The network helps show where Mikhail Gilyarov may publish in the future.

Co-authorship network of co-authors of Mikhail Gilyarov

This figure shows the co-authorship network connecting the top 25 collaborators of Mikhail Gilyarov. A scholar is included among the top collaborators of Mikhail Gilyarov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikhail Gilyarov. Mikhail Gilyarov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

2 of 2 papers shown
#WorkIndexed citations
1 35
2 2

About Mikhail Gilyarov

Mikhail Gilyarov is a scholar working on Obstetrics and Gynecology, Endocrinology, Diabetes and Metabolism and Infectious Diseases, having authored 2 papers that have together received 37 indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (1 paper), Metabolism, Diabetes, and Cancer (1 paper) and COVID-19 Clinical Research Studies (1 paper). The work is most often cited by research in Infectious Diseases (20 citations), Neurology (16 citations) and Immunology (7 citations). Mikhail Gilyarov has collaborated with scholars based in Russia. Frequent co-authors include Е. А. Smolyarchuk, Mazurov Vi, И. Г. Гордеев, Vladimir O. Popov, Д. Н. Проценко, N. V. Lomakin, Daria Fomina, О. М. Моисеева and G. R. Galstyan. Their work appears in journals such as Inflammation Research and Diabetes Mellitus.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026